DalCor Pharmaceuticals secures $80m in Series D financing

Based in Montreal, DalCor Pharmaceuticals is a biopharmaceutical company with a focus on addressing cardiovascular disease.

13 September 2023•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Canada North America Deals & Exits Briefs